Total Funding
21
Total FundingSeries A raised
Growth Score
pts
Heat Score
9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Zumbro is a biotechnology company committed to the clinical development of novel peptides for cardiovascular and metabolic disease.
John Burnett: Co-Founder- Horng Chen: Co-Founder
About the Company
Zumbro Discovery, Inc. is developing a novel natriuretic peptide, MANP, for the treatment of resistant hypertension for which there is an unmet medical need for a syndrome which increases risk for heart failure, myocardial infarction, stroke and kidney disease. MANP was discovered at the Mayo Clinic and is soon entering first in human studies.
